A differential ligand-mediated response of green fluorescent protein-tagged androgen receptor in living prostate cancer and non-prostate cancer cell lines

Journal of Histochemistry and Cytochemistry

Volumn 55, Issue 6, 2007, Pages 535-544

  Nakauchi, Hiroo ^a   Matsuda, Ken Ichi ^a   Ochiai, Ikuo ^a   Kawauchi, Akihiro ^a   Mizutani, Yoichi ^a   Miki, Tsuneharu ^a   Kawata, Mitsuhiro ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Androgen receptor; GFP; Hormone sensitivity; Live cell imaging; Prostate cancer

Indexed keywords

ANDROGEN RECEPTOR; GREEN FLUORESCENT PROTEIN; PROTEIN TAG;

ANDROGEN BLOOD LEVEL; ARTICLE; CANCER CELL CULTURE; CELL MIGRATION; CELL NUCLEUS; CELL STRAIN COS1; CELL STRAIN LNCAP; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE CLUSTER; GENE TRANSLOCATION; HORMONE SENSITIVITY; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN LOCALIZATION;

ANDROGENS; ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL NUCLEUS; CERCOPITHECUS AETHIOPS; COS CELLS; CYTOPLASM; DOSE-RESPONSE RELATIONSHIP, DRUG; GREEN FLUORESCENT PROTEINS; HUMANS; MALE; MICROSCOPY, CONFOCAL; MUTANT PROTEINS; MUTATION; PROSTATIC NEOPLASMS; PROTEIN TRANSPORT; RECEPTORS, ANDROGEN; RECOMBINANT FUSION PROTEINS; TIME FACTORS; TRANSFECTION;

EID: 34249036771     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1369/jhc.6A7064.2007     Document Type: Article

References (48)

1. Alen P, Claessens F, Verhoeven G, Rombauts W, Peeters B (1999) The androgen receptor amino-terminal domain plays a key role in p160 coactivator-stimulated gene transcription. Mol Cell Biol 19:6085-6097
2. Alimirah F, Chen J, Basrawala Z, Xin H, Choubey D (2006) DU-145 and PC-3 human prostate cancer cell lines express androgen receptor: implications for the androgen receptor functions and regulation. FEBS Lett 580:2294-2300
3. Black BE, Paschal BM (2004) Intranuclear organization and function of the androgen receptor. Trends Endocrinol Metab 15:411-417
4. Black BE, Vitto MJ, Gioeli D, Spencer A, Afshar N, Conaway MR, Weber MJ, et al. (2004) Transient, ligand-dependent arrest of the androgen receptor in subnuclear foci alters phosphorylation and coactivator interactions. Mol Endocrinol 18:834-850
5. Chang CS, Kokontis J, Liao ST (1985) Structural analysis of complementary DNA and amino acid sequences of human and rat androgen receptors. Proc Natl Acad Sci USA 85:7211-7215
6. Eisenfeld AJ (1975) Characteristics of steroid hormone receptors in brain and pituitary. In Stumpf WE, Grant LD, eds. Anatomical Neuroendocrinology. Basel, Karger, 52-61
7. Farla P, Hersmus R, Trapman J, Houtsmuller AB (2005) Antiandrogens prevent stable DNA-binding of the androgen receptor. J Cell Sci 118:4187-4198
8. Gaddipati JP, McLeod DG, Heidenberg HB, Sesterhenn IA, Finger MJ, Moul JW, Srivastava S (1994) Frequent detection of codon 877 mutation in the androgen receptor gene in advanced prostate cancers. Cancer Res 54:2861-2864
9. Gelmann EP (2002) Molecular biology of the androgen receptor. J Clin Oncol 20:3001-3015
10. Georget V, Lobaccaro JM, Terouanne B, Mangeat P, Nicolas JC, Sultan C (1997) Trafficking of the androgen receptor in living cells with fused green fluorescent protein-androgen receptor. Mol Cell Endocrinol 129:17-26
11. Gottlieb B, Beitel LK, Wu JH, Trifiro M (2004) The androgen receptor gene mutations database (ARDB): 2004 update. Hum Mutat 23:527-533
12. Gregory CW, He B, Johnson RT, Ford OH, Mohler JL, French FS, Wilson EM (2001) A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy. Cancer Res 61:4315-4319
13. Grossmann ME, Huang H, Tindall DJ (2001) Androgen receptor signaling in androgen-refractory prostate cancer. J Natl Cancer Inst 93:1687-1697
14. Hager GL, Lim CS, Elbi C, Baumann CT (2000) Trafficking of nuclear receptors in living cells. J Steroid Biochem Mol Biol 74:249-254
15. Heinlein CA, Chang C (2004) Androgen receptor in prostate cancer. Endocr Rev 25:276-308
16. Huggins C, Hodges CV (1941) Studies on prostatic cancer: the effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res 1:293-297
17. Karvonen U, Janne OA, Palvimo JJ (2002) Pure antiandrogens disrupt the recruitment of coactivator GRIP1 to colocalize with androgen receptor in nuclei. FEBS Lett 523:43-47
18. Kawata M, Matsuda K, Nishi M, Ogawa H, Ochiai I (2001) Intracellular dynamics of steroid hormone receptor. Neurosci Res 40:197-203
19. Kumar S, Saradhi M, Chaturvedi NK, Tyagi RK (2006) Intracellular localization and nucleocytoplasmic trafficking of steroid receptors: an overview. Mol Cell Endocrinol 246:147-156
20. Linja MJ, Porkka KP, Kang Z, Savinainen KJ, Janne OA, Tammela TL, Vessella RL, et al. (2004) Expression of androgen receptor coregulators in prostate cancer. Clin Cancer Res 10:1032-1040
21. Lu S, McKenna SE, Cologer-Clifford A, Nau EA, Simm NG (1998) Androgen receptor in mouse brain: sex differences and similarities in autoregulation. Endocrinology 139:1594-1601
22. Ma H, Hong H, Huang SM, Irvine RA, Webb P, Kushner PJ, Coetzee GA, et al. (1999) Multiple signal input and output domains of the 160-kilodalton nuclear receptor coactivator proteins. Mol Cell Biol 19:6164-6173
23. MacLean HE, Warne GL, Zajac JD (1997) Localization of functional domains in the androgen receptor. J Steroid Biochem Mol Biol 62:233-242
24. McDonald S, Brive L, Agus DB, Scher HI, Ely KR (2000) Ligand responsiveness in human prostate cancer: structural analysis of mutant androgen receptors from LNCaP and CWR22 tumors. Cancer Res 60:2317-2322
25. Nordeen SK, Housley PR, Wan Y, Day RN (2001) Application of green fluorescent protein to the study of dynamic protein-protein interactions and subcellular trafficking of steroid receptors. Methods Mol Biol 176:179-199
26. Ochiai I, Matsuda K, Nishi M, Ozawa H, Kawata M (2004) Imaging analysis of subcellular correlation of androgen receptor and estrogen receptor α in single living cells using green fluorescent protein color variants. Mol Endocrinol 18:26-42
27. Palmberg C, Koivisto P, Visakorpi T, Tammela TL (1999) PSA decline is an independent prognostic marker in hormonally treated prostate cancer. Eur Urol 36:191-196
28. Picard D, Yamamoto KR (1987) Two signals mediate hormone-dependent nuclear localization of the glucocorticoid receptor. EMBO J 6:3333-3340
29. Poukka H, Karvonen U, Janne OA, Palvimo JJ (2000) Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1). Proc Natl Acad Sci USA 97:14145-14150
30. Pratt WB, Galigniana MD, Morishima Y, Murphy PJ (2004) Role of molecular chaperones in steroid receptor action. Essays Biochem 40:41-58
31. Press MF, Greene GL (1988) Immunocytochemical localization estrogen progesterone receptors. In DeLellis R, ed. Advances in Immunohistochemistry. New York, Raven Press, 341-361
32. Prins GS, Birch L, Greene GL (1991) Androgen receptor localization in different cell types of the adult rat prostate. Endocrinology 129:3187-3199
33. Shimomura O, Johnson FH, Saiga Y (1962) Extraction, purification and properties of aequorin, a bioluminescent protein from the luminous hydromedusan, Aequorea. J Cell Comp Physiol 59:223-239
34. Simental JA, Sar M, Lane MV, French FS, Wilson EM (1991) Transcriptional activation and nuclear targeting signals of the human androgen receptor. J Biol Chem 266:510-518
35. Simental JA, Sar M, Wilson EM (1992) Domain functions of the androgen receptor. J Steroid Biochem Mol Biol 43:37-41
36. Stumpf WE (1983) The histochemistry of steroid hormone "receptors". J Histochem Cytochem 31:113-114
37. 3H- mesobilirubinogen. J Histochem Cytochem 14:274-287
38. Suzuki H, Akakura K, Komiya A, Aida S, Akimoto S, Shimazaki J (1996) Codon 877 mutation in the androgen receptor gene in advanced prostate cancer: relation to antiandrogen withdrawal syndrome. Prostate 29:153-158
39. Taplin ME, Bubley GJ, Shuster TD, Frantz ME, Spooner AE, Ogata GK, Keer HN, et al. (1995) Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer. N Engl J Med 332:1393-1398
40. Tenbaum S, Baniahmad A (1997) Nuclear receptors: structure, function and involvement in disease. Int J Biochem Cell Biol 29:1325-1341
41. Tilley WD, Bentel JM, Aspinall JO, Hall RE, Horsfall DJ (1995) Evidence for a novel mechanism of androgen resistance in the human prostate cancer cell line, PC-3. Steroids 60:180-186
42. Tilley WD, Buchanan G, Hickey TE, Bentel JM (1996) Mutations in the androgen receptor gene are associated with progression of human prostate cancer to androgen independence. Clin Cancer Res 2:277-285
43. Tomura A, Goto K, Morinaga H, Nomura M, Okabe T, Yanase T, Takayanagi R, et al. (2001) The subnuclear three-dimensional image analysis of androgen receptor fused to green fluorescence protein. J Biol Chem 276:28395-28401
44. Tyagi RK, Lavrovsky Y, Ahn SC, Song CS, Chatterjee B, Roy AK (2000) Dynamics of intracellular movement and nucleocytoplasmic recycling of the ligand-activated androgen receptor in living cells. Mol Endocrinol 14:1162-1174
45. Veldscholte J, Ris-Stalpers C, Kuiper GG, Jenster G, Berrevoets C, Claassen E, van Rooij HC, et al. (1990) A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to antiandrogens. Biochem Biophys Res Commun 173:534-540
46. Walsh PJ, Teasdale J, Cowen PN (1990) Ultrastructural localisation of oestrogen receptor in breast cancer cell nuclei. Histochemistry 95:205-207
47. Yeh S, Chang HC, Miyamoto H, Takatera H, Rahman M, Kang HY, Thin TH, et al. (1999) Differential induction of the androgen receptor transcriptional activity by selective androgen receptor coactivators. Keio J Med 48:87-92
48. Zhou ZX, Sar M, Simental JA, Lane MV, Wilson EM (1994) A ligand-dependent bipartite nuclear targeting signal in the human androgen receptor: requirement for the DNA-binding domain and modulation by NH2-terminal and carboxyl-terminal sequences. J Biol Chem 269:13115-13123